Mars to invest US$1.4B in US manufacturing in 2027
Mars has invested more than $9 billion in US manufacturing and operations in the last decade.
USA – Mars, Incorporated, has announced plans to invest approximately US$1.4 billion in its US manufacturing and operations footprint in 2027, marking the largest single-year investment in the company’s domestic operations.
The commitment is intended to expand manufacturing capabilities, accelerate product innovation, modernize production facilities and strengthen supply chain resilience across its diverse portfolio of food, snack and pet care brands.
The investment builds on more than US$9 billion that Mars has committed to its US operations since 2017.
The company said the latest investment would support long-term growth, improve operational efficiency and contribute to economic development in communities where it operates.
According to Claus Aagaard, Mars’ Chief Financial Officer, about 94% of the products the company sells in the US are manufactured domestically.
He noted that continued investment in local manufacturing would strengthen production capabilities, support innovation and help the company respond to changing consumer requirements.
As part of the 2027 commitment, Mars plans to invest more than US$34 million early next year to establish four new veterinary hospitals under its Mars Veterinary Health division.
The facilities will include three BluePearl Pet Hospitals in Ellicott City, Maryland, and Austin and Katy, Texas, as well as a Banfield Pet Hospital in Wilmington, North Carolina.
The developments are expected to create up to 195 jobs and expand access to specialized veterinary and emergency care.
The announcement also highlighted several manufacturing investments undertaken during 2026. In Salt Lake City, Utah, Mars committed US$60 million to install two dedicated manufacturing lines for its Trü Frü frozen fruit products within its Nature’s Bakery facility.
The expansion will provide annual production capacity for about 17 million frozen products, along with more than one billion Nature’s Bakery snack bars.
In Waco, Texas, the company has invested US$165 million since 2024 to improve energy efficiency and operational performance at its manufacturing facility, which produces more than 56 billion pieces of Snickers, Starburst and Skittles annually.
Meanwhile, a US$49 million investment in its Columbus, Ohio, wet pet food facility will introduce advanced mixing and filling technologies for Temptations Lickable Treats, creating capacity to manufacture more than 400 million pouches annually.
The expansion follows Mars’ US$36 billion acquisition of Kellanova in 2025, which added 15 manufacturing facilities to its network.
The company now employs approximately 80,000 associates across more than 60 factories, research laboratories and offices, in addition to over 2,000 veterinary clinics and hospitals.
Through the investment programme, Mars aims to strengthen its domestic manufacturing network, improve production efficiency and maintain the capacity to supply its growing portfolio of consumer food and pet care products.
Sign up to HERE receive our email newsletters with the latest news and insights from Africa and around the world, and follow us on our WhatsApp channel for updates.
